Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine and celecoxib for treatment-resistant seizures
IRCT20250923067340N1Phase 2Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of memantine and celecoxib in seizure, sponsored by Ardabil University of Medical Sciences. Primary endpoints: Change in number of seizures and Change in serum inflammatory markers. Started Oct 2025; status: completed.
02
Drugs
memantinecelecoxib
03
Conditions
seizure
Beyond the preview
Go deeper on IRCT20250923067340N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250923067340N1.